Man så en sammenhæng mellem mutationsscoren for tipranavir og responsen over for APTIVUS/ ritonavir- behandling ved uge 48.
A correlation between the tipranavir mutation score and response to APTIVUS/ ritonavir therapy at week 48 has been established.